ICECURE MEDICAL LTD (ICCM) Forecast, Price Target & Analyst Ratings

NASDAQ:ICCM • IL0011224156

Current stock price

0.3491 USD
+0.05 (+15.71%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ICECURE MEDICAL LTD (ICCM).

Forecast Snapshot

Consensus Price Target

Price Target
$3.11
+ 791.15% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.05
Revenue Estimate
1.491M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.11
Upside
+ 791.15%
From current price of $0.35 to mean target of $3.11, Based on 8 analyst forecasts
Low
$3.03
Median
$3.11
High
$3.26

Price Target Revisions

1 Month
-2.40%
3 Months
-2.40%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for ICCM. The average price target is 3.11 USD. This implies a price increase of 791.15% is expected in the next year compared to the current price of 0.3491.
The average price target has been revised downward by 2.4% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ICCM Current Analyst RatingICCM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ICCM Historical Analyst RatingsICCM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
ICCM was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ICCM.
In the previous month the buy percentage consensus was at a similar level.
ICCM was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-10-07HC Wainwright & Co.Maintains Buy -> Buy
2025-08-15HC Wainwright & Co.Maintains Buy -> Buy
2025-05-29HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-28HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-27HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-21HC Wainwright & Co.Maintains Buy -> Buy
2024-07-02HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-05HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-29HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-04HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-20Alliance Global PartnersMaintains Buy -> Buy
2024-03-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-05HC Wainwright & Co.Reiterate Buy -> Buy
2023-11-29HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-06HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-15Alliance Global PartnersMaintains Buy -> Buy
2023-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2023-07-25HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-01HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-23HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-28HC Wainwright & Co.Reiterate Buy
2023-03-20HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.05
Revenue Estimate
1.491M
Revenue Q2Q
105.66%
EPS Q2Q
23.50%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
61.34%
Revenue (3 Months)
61.34%
EPS (1 Month)
10.00%
EPS (3 Months)
10.00%

Next Earnings Summary

ICCM is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.05 USD and the consensus revenue estimate is 1.49M USD.
The next earnings revenue estimate has been revised upward by 61.34% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ICCM revenue by date.ICCM revenue by date.
3.229M
4.50%		3.291M
1.92%		3.379M
2.67%		8.093M
139.51%		14.216M
75.66%		34.373M
141.79%		88.607M
157.78%		109.11M
23.14%		124.87M
14.44%		134.95M
8.07%		143.15M
6.08%
EBITDA
YoY % growth
ICCM ebitda by date.ICCM ebitda by date.
-15.253M
7.50%		-15.364M
-0.73%		-14.799M
3.68%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ICCM ebit by date.ICCM ebit by date.
-15.576M
6.95%		-15.696M
-0.77%		-15.094M
3.84%		-14.519M
3.81%		-5.928M
59.17%		-3.476M
41.36%		19.143M
650.69%		25.095M
31.09%		29.97M
19.43%		33.738M
12.57%		37.22M
10.32%
Operating Margin
ICCM operating margin by date.ICCM operating margin by date.
-482.38%-476.94%-446.70%-179.40%-41.70%-10.11%21.60%23.00%24.00%25.00%26.00%
EPS
YoY % growth
ICCM eps by date.ICCM eps by date.
-0.31
31.65%		-0.30
3.85%		-0.25
16.67%		-0.15
40.84%		-0.07
51.72%		0.11
257.14%		0.27
136.36%		0.35
30.77%		0.42
20.59%		0.35
-17.07%		0.38
8.82%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.05
23.50%		-0.05
23.50%		-0.05
23.50%		-0.05
34.43%
Revenue
Q2Q % growth		1.491M
105.66%		1.803M
243.43%		2.167M
154.94%		2.632M
105.79%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-3.868M
-5.78%		-3.9M
-15.21%		-3.924M
-2.31%		-4.255M
-0.92%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ICCM Yearly Revenue VS EstimatesICCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M
ICCM Yearly EPS VS EstimatesICCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 -0.2 0.4 -0.4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
34.79%
EPS Next 5 Year
27.63%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
105.77%
Revenue Next 5 Year
94.25%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ICECURE MEDICAL LTD / ICCM Forecast FAQ

Can you provide the average price target for ICECURE MEDICAL LTD stock?

8 analysts have analysed ICCM and the average price target is 3.11 USD. This implies a price increase of 791.15% is expected in the next year compared to the current price of 0.3491.

When does ICECURE MEDICAL LTD (ICCM) report earnings?

ICECURE MEDICAL LTD (ICCM) will report earnings on 2026-05-06.

What are the consensus estimates for ICCM stock next earnings?

The consensus EPS estimate for the next earnings of ICECURE MEDICAL LTD (ICCM) is -0.05 USD and the consensus revenue estimate is 1.49M USD.

What is the expected long term growth rate for ICECURE MEDICAL LTD (ICCM)?

The expected long term growth rate for ICECURE MEDICAL LTD (ICCM) is 105.77%.